Distributed analyses of disease risk and association across networks of de-identified medical systems by McMurry, Andrew John
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2015
Distributed analyses of disease risk
and association across networks of
de-identified medical systems
https://hdl.handle.net/2144/14002
Boston University
 
 
Supplemental material 
 
DISTRIBUTED	  ANALYSES	  OF	  DISEASE	  RISK	  AND	  ASSOCIATION	  
ACROSS	  NETWORKS	  OF	  DE-­‐IDENTIFIED	  MEDICAL	  SYSTEMS	  
 
by 
 
ANDREW J. McMurry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ANDREW J. McMurry 
 CC-BY Creative Commons LIcense 
 
  
	  	   iii 
TABLE OF CONTENTS 
 
TABLE OF CONTENTS ................................................................................................ iii	  
LIST OF TABLES ........................................................................................................... vi	  
LIST OF FIGURES ........................................................................................................ vii	  
CHAPTER FOUR SUPPLEMENT ................................................................................ 9	  
S4.1	   Study criteria ........................................................................................................ 9	  
S4.2	   Patient criteria .................................................................................................... 10	  
S4.3	   Diagnosis and procedure criteria ....................................................................... 12	  
S4.4	   Hospital criteria ................................................................................................. 13	  
S4.5	   Excluded hospitals ............................................................................................. 14	  
S4.6	   Mapping clinical concepts in acute care settings  .............................................. 15	  
S4.7	   Visit source ........................................................................................................ 16	  
S4.8	   Visit type ............................................................................................................ 18	  
S4.9	   Departure status ................................................................................................. 19	  
S4.10	   Patient visit sequence to hospital departments ................................................ 20	  
CHAPTER FIVE SUPPLEMENT ................................................................................ 22	  
S5.1	   Observational and prospective studies using EHRs .......................................... 22	  
S5.2	   Methods for aggregation .................................................................................... 24	  
S5.2.1	   Method to aggregate patient diagnoses ....................................................... 24	  
S5.2.2	   Method to aggregate patient procedures ..................................................... 26	  
	  	   iv 
S5.2.3	   Graph properties of disease and procedure hierarchies .............................. 27	  
S5.3	   Summary ............................................................................................................ 28	  
CHAPTER SIX SUPPLEMENT ................................................................................... 35	  
S6.1	   Overview ............................................................................................................ 35	  
S6.2	   Comorbidity selections ...................................................................................... 38	  
S6.3	   Procedure selections .......................................................................................... 39	  
S6.4	   Aggregating weakly associated ICD9 codes can reveal strong relationships in 
diagnosis categories. ..................................................................................................... 40	  
S6.5	   AMI comorbidities by disease system ............................................................... 41	  
S6.6	   Circulatory system: diseases of arteries and capillaries .................................... 42	  
S6.7	   Circulatory system: hypertension ...................................................................... 43	  
S6.8	   Diseases of endocrine; nutritional; metabolic diseases; immunity disorders .... 44	  
S6.9	   Diseases of the blood and blood-forming organs .............................................. 45	  
S6.10	   Diseases of the genitourinary system .............................................................. 46	  
S6.11	   Diseases of the respiratory system ................................................................... 47	  
S6.12	   Infectious and parasitic diseases ...................................................................... 47	  
S6.13	   Diseases of the nervous system and sense organs ........................................... 48	  
S6.14	   Diseases of musculoskeletal system and connective tissue ............................. 49	  
S6.15	   Neoplasms ........................................................................................................ 49	  
S6.16	   Mental illness and substance abuse ................................................................. 50	  
S6.17	   Diseases of the digestive system ...................................................................... 51	  
S6.18	   Injury and poisoning ........................................................................................ 52	  
	  	   v 
S6.19	   Unclassified diagnoses ..................................................................................... 52	  
S6.20	   Selections by operation type ............................................................................ 52	  
CHAPTER SEVEN SUPPLEMENT ............................................................................ 54	  
S7.1	   Baseline model for each local patient population .............................................. 54	  
S7.2	   Baseline model: train at MGH and test on each hospital ................................... 55	  
S7.3	   Baseline model: train at each hospital, test on MGH ........................................ 56	  
S7.4	   Comorbidity selection for AMI risk prediction ................................................. 57	  
S7.5	   Consensus models for robust AMI prediction in hospital networks .................. 59	  
S7.6	   Prediction results summary ................................................................................ 62	  
S7.7	   Baseline model AMI prediction results ............................................................. 65	  
BIBLIOGRAPHY FOR SUPPLEMENT ..................................................................... 70	  	  
  
	  	   vi 
LIST OF TABLES 
Table S4.1	   Study criteria summary ................................................................................ 10	  
Table S4.2 Patient inclusion criteria. ................................................................................ 12	  
Table S4.3 Clinical concept code criteria. ........................................................................ 13	  
Table S4.4	   Hospital inclusion criteria. ........................................................................... 14	  
Table S4.5	   List of hospitals that did not meet inclusion criteria. .................................. 15	  	  	  
  
	  	   vii 
LIST OF FIGURES 
Figure S4.6	   Mapping clinical concepts in acute care settings. ...................................... 15	  
Figure S4.7 Visit source of first patient visit. ................................................................... 17	  
Figure S4.8 Visit type of first patient visit . ...................................................................... 18	  
Figure S4.9 Departure status for first patient visit. ........................................................... 19	  
Figure S4.10 Example heart attack visit sequence involving several hospitals and 
departments. Simulated example. ............................................................................. 21	  
Figure S5.1. CCS diagnoses hierarchy of Acute Myocardial Infarction. ......................... 25	  
Figure S5.2	   Statewide AMI risk by gender. .................................................................. 29	  
Figure S5.3: Histogram of relative risk by gender for all 73 hospitals meeting criteria. .. 30	  
Figure S5.4: Cumulative distribution of AMI patient visits by age. ................................. 31	  
Figure S5.5. AMI patient age distributions: hospitals vs. state average. .......................... 32	  
Figure S5.6: Relative risk of AMI by race. ....................................................................... 33	  
Figure S5.7	   Procedure frequencies in Massachusetts by procedure type. ..................... 34	  	  
  
	  	   viii 
 
	  	  
9 
CHAPTER FOUR SUPPLEMENT 
 
S4.1 Study criteria 
 
This chapter 4 supplement contains detailed study criteria and summary statistics for 
how patients visit different hospital departments across Massachusetts. Heart attack study 
criteria was defined and evaluated for hospitals, patients, and clinical concepts. Patient 
visits are reported with regards to visit source, visit type, and visit sequence. Nearly all 
patients in this dataset had fewer than 5 acute care visits to any department. 
 
Met all criteria  
(AMI patients) 
  80K patients (65%) 
430K visits    (44%)  
 
 
Met all criteria  
(Unaffected) 
 
 
   3M patients (62%)  
 14M visits    (74%)  
Met all criteria  
(All patients) 
   3M patients (62%)  
 14M visits    (74%)  
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Table S4.1 Study criteria summary  
 
 
 
S4.2 Patient criteria 
 
Each patient must have more than one visit to allow for AMI prediction to occur. Patients 
must be adults over 18 years old and pass age consistency checks. Patients must have 
fewer than one visit per month over a 12 year period to filter out a few cases of severely 
sick patients that are most likely invalid hospital data.  
 
More than half of patients met all criteria (66%). 62% patients have at least one visit and 
no more than one visit per month for seven years consecutively. Patient visit dates and 
ages were possible given the sequence of visit dates. 38% did not meet visit criteria. 54% 
of all patients matched visit criteria and adult age criteria (65% AMI cases, 53% 
unaffected).  
 
Inclusion criteria Met criteria Did not meet criteria 
Patient must have 
more than 1 visit 
 
63% patients had 2 or 
more visits  
• Patients with no clinical history 
required for prediction.  
Patient must have 
fewer than 84 visits: 
>99% patients had 
fewer than 84 visits 
• Patients with extreme health 
care utilization 
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12 months x 7 years 
 
• Patient visit record failed QC 
Patient visit dates and 
ages must be possible 
over 7 year period 
 
98% patients had 
explainable visit date 
sequences. 
• Patient visit record failed QC 
Patient must be an 
adult aged 18+  
(context dependent) • Pediatrics  
• Demographic data failed QC 
Met all criteria  
(AMI patients) 
 
80K patients (65%) 
430K visits    (44%)  
 
 
• AMI patients who had an AMI 
on first visit (no clinical history, 
this was most likely) 
• Severe data QC failures 
• Unexplainable severity 
 
Met all criteria  
(Unaffected) 
 
 
3M patients (62%)  
14M visits    (74%)  
 
• Patients with only one visit 
• Severe data QC failures 
• Unexplainable severity 
 
Met all criteria  
(All patients) 
3M patients (62%)  
14M visits    (74%)  
 
• Patients with no clinical history 
required for prediction  
• Severe data QC failures 
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• Unexplainable severity 
 
Table S4.2 Patient inclusion criteria.  
 
 
S4.3 Diagnosis and procedure criteria  
 
Each clinical concept must be observed in at least 100 patients in the state of 
Massachusetts. Most concepts such as ICD9 diagnoses codes required aggregated 
grouping to have 100+ patients for analysis.  
 
7,8333 clinical concept codes including diagnosis, procedures, and demographic terms 
had at least 100 patients prior to the study. Clinical concept codes that did not meet 
criteria must first be aggregated so that there is at least 100 patients in the population 
being tested.  
 
Inclusion criteria Met criteria Did not meet criteria 
Must be recorded for 
at least 100 patients 
 
7,833 concept codes did 
not require aggregation 
(33%)  
• 15,773 rarely recorded clinical 
concept codes. Requires concept 
aggregation prior to study. For 
example, subtypes of rare 
diseases.  
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Table S4.3 Clinical concept code criteria.  
 
 
S4.4 Hospital criteria 
 
Each hospital must provide services in all three departments to allow for statewide 
comparison. Departments include inpatient, outpatient, and emergency. Each hospital 
must observe at least 100 unique patients who had a heart attack (AMI).  Most hospitals 
met criteria but some did not, such as hospitals with emergency-only services or pediatric 
populations.  
 
Inclusion criteria Met criteria Did not meet criteria 
Hospital must have 
inpatient, outpatient, and 
emergency departments. 
 
77 of 88 hospitals  • Service specific hospitals 
• “Cautionary use” hospitals 
• Hospitals/clinics with limited 
services 
Hospital must see at least 
100 AMI cases.  
 
74 of 88 hospitals • Children’s Hospital Boston  
 
All inclusion criteria for 
hospital departments and 
83% of hospitals. 
(73 of 88 hospitals)  
• Service specific hospitals 
• “Cautionary use” hospitals 
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case sizes  • Hospitals/clinics with  
limited services 
• Children’s Hospital Boston 
 
Table S4.4 Hospital inclusion criteria.  
Hospitals must have all three departments and see at least 100 unique patients diagnosed 
with an AMI. Hospitals that did not meet inclusion criteria were removed from the study.  
 
S4.5 Excluded hospitals 
 
           MADPH provided hospital name  
1. Berkshire Medical Center - Hillcrest Campus  
2. Children’s Hospital Boston  
3. Dana-Farber Cancer Institute  
4. Hallmark Health Care / CHA - Malden (closed)  
5. Massachusetts Eye and Ear Infirmary  
6. New England Baptist Hospital  
7. Mercy Hospital - Providence Behavioral Health Hospital Campus  
8. Kindred Hospital Boston North Shore  
9. Kindred Hospital Boston  
10. Caritas Good Samaritan Southwood  
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11. Cable Emergency Center (closed)  
12. Lahey Clinic North Shore  
13. Caritas Good Samaritan Medical Center Norcap Lodge Campus 
14. Health Alliance Hospital: Leominster Campus  
15. Health Alliance Hospital: Burbank Campus  
 
Table S4.5 List of hospitals that did not meet inclusion criteria. 
 
 
S4.6 Mapping clinical concepts in acute care settings 
 
 
 
Figure S4.6 Mapping clinical concepts in acute care settings.  
Each patient visit to a hospital department includes the demographic terms (Gender, race, 
age at visit, 3 digit zip code). Visit metadata includes visit source and visit type metadata 
standardized by MADPH. Each patient visit was to one department (ED: Emergency 
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department visit, OBS: Outpatient observation stay, or INPT: Inpatient hospitalization 
stay). ED diagnoses were principal, associated, and E-codes. OBS diagnoses were 
principal and associated. INPT diagnosis were not differentiated as principal or 
associated, up to 15 diagnoses were recorded for a single INPT hospitalization. INPT 
stays include up to 15 procedure codes for one hospitalization stay (visit).  
 
 
S4.7 Visit source 
 
73% of patients visited the Emergency Department as a walk-in or self-referral (54%). 
Inpatient hospitalizations were 23% of all first patient visits most often by direct 
physician referral (36%). Outpatient observations were only 4% of first patient visits, and 
were almost always a direct physician referral (38%) or emergency transfer inside (28%) 
or outside (14%) of the hospital.  
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Figure S4.7 Visit source of first patient visit.   
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S4.8 Visit type  
 
73% of patients visited the Emergency department for emergencies (56%) with many 
urgent care visits (28%). Inpatient hospitalizations were 23% of all first patient visits 
typically for emergency care (50%). Outpatient observations were only 4% of first patient 
visits, and were typically for emergencies (48%). 
 
 
 
Figure S4.8 Visit type of first patient visit . 
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S4.9 Departure status  	  
Most patients were routinely discharged from emergency and outpatient care settings. 
Only inpatient care resulted in low rates of routine discharge: inpatient (58%) vs. 
emergency (93%), outpatient (90%). Inpatient care patients where often transferred to 
health organizations and skilled nursing facilities that may not be in this dataset, which 
makes the prediction task even more challenging.  
 
 
 
Figure S4.9 Departure status for first patient visit.  
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S4.10 Patient visit sequence to hospital departments 
 
Simulated patient example  
Patient with a COPD complication had trouble breathing while at work and he was 
rushed to the nearest emergency department (Figure S4.X). This is the first visit record 
for the patient at any hospital. Roughly a year later, the same patient complains of acute 
chest pains while at home and he is again rushed to nearest emergency department near 
his home. The previous ED visit data is from hospital H1 to hospital H2. Emergency 
department physicians quickly determine the patient is at severe risk of heart attack and 
admit him for inpatient care. During the inpatient stay, the patient is indeed diagnosed 
with Acute Myocardial Infarction. Roughly a week later, the patient returns for 
observation by a cardiologist at a specialty service hospital (H3). The cardiologist at 
hospital H3 receives previous ED and inpatient visit records. 
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Figure S4.10 Example heart attack visit sequence involving several hospitals and 
departments. Simulated example.  
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CHAPTER FIVE SUPPLEMENT 	  
S5.1 Observational and prospective studies using EHRs 	  
In a typical EHR system, there are as many patient phenotypes as human genes, ~25,000 
concepts including ICD9 diagnoses, CPT procedures, and LOINC lab tests[1]. By 
analogy, consider the hypothetical scenario where you are asked to analyze gene 
expression microarrays that use different gene nomenclature to describe similar but not 
identical biological processes. How would you aggregate and analyze these different 
microarray experiments? Such is the challenge with EHR data: the clinical concept 
nomenclature can be different but the general category of clinical observation should be 
similar. If two patients with the same disease are recorded differently at different 
hospitals, it should still be possible to find a similar category of the disease.  
 
Methods to control variation exist at different stages of the study from design to 
execution. In the study design phase, variation can be controlled by carefully selecting 
hospitals, patients, and outcome measurements. A typical way to measure variation is to 
use ANOVA methods and related tests for normalcy and goodness of fit. However, as the 
number of variables in the study increases, controlling for variation becomes all the more 
difficult. Consider a simple ANOVA of patient demographics: age is not a normal 
variable and race and ethnicity may have multiple related encodings. Consider again how 
many ANOVA measures (t-tests) would be needed to quantify the similarities between all 
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diseases and disease pairings, especially given that co-morbid diseases are by definition 
not independent.  
 
Observational studies often merge all patients into one dataset and then carry out the 
analysis. Even when centralized aggregation is permissible, case mixing may hide 
population variances and other sources of variation. Consider a heart attack study 
involving many different pediatric and adult populations – it should be expected that the 
pediatric cases should not be included. But what if many general populations are 
included? When there is no clearly defined age separation then age inclusion criteria will 
need to be defined in the case definition. If age is the only variable that differs in the 
study population, then this would be sufficient for many studies. Unfortunately age is not 
the only source of variation: patients, hospitals, and records all contribute to study bias. 
As a simple example, if a hospital has no inpatient services then only heart attacks 
occurring the emergency department are recorded. In a sense, adding more populations 
increases the number of ways that variation can play a role, even if this variation is 
masked by belief that we are approaching the “normal” population.  
 
Prospective studies are intentionally designed to minimize variation by carefully selecting 
patient cases with very similar characteristics. Inclusion criteria that is more strict 
necessarily reduces case sizes, which often has the effect that the study is underpowered 
especially for diseases with low prevalence. This means that prospective studies often 
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attempt to study patients from more than one hospital, however, there is often no way to 
search for such patients due to the political and technical challenges.  
 
S5.2 Methods for aggregation 
 
First, we aggregate patient diagnoses and procedures to reduce medical coding variation 
and reduce sparsity in the patient feature matrix. We provide step by step instructions for 
aggregating the data and we define the constraints on the aggregation method.  
 
Second, we calculate the association of heart attack at each hospital using patient 
demographic factors: gender, age, race, and geography. The association for each AMI 
covariate is tested for significance, and the differences between hospitals are recorded for 
each covariate.  
 
S5.2.1 Method to aggregate patient diagnoses  	  
The CCS disease hierarchy was created to categorize ICD9 codes into 18 distinct disease 
systems. The hierarchy contains 5 levels where the top level (Level 1), is the most 
general diagnosis category, also referred to as disease system, CCS diagnosis levels 2,3,4 
are subcategories of the disease system, and level 5 contains only ICD9 codes. Each 
diagnosis category can have mappings to one or more ICD9 codes. For each patient, we 
aggregate diagnoses hierarchically by recursively summing up the diagnoses beginning 
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with the bottom of the hierarchy (individual ICD9 codes) and ending at the top of the 
hierarchy (disease system). Figure S5.1 illustrates the diagnoses hierarchy for Acute 
Myocardial Infarction (AMI).  
 
 
Figure S5.1 CCS diagnoses hierarchy of Acute Myocardial Infarction.  
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“Diagnoses” includes all 18 disease systems and therefore all ICD9 diagnosis codes. 
Acute MI is in the disease system labeled “Diseases of the circulatory system”. 
Circulatory system includes the subcategory “7.2 Diseases of the heart” which in turn 
includes the subcategory “7.2.3 Acute Myocardial Infarction”. The AMI category 
includes ICD9 410, which in tern includes the ten ICD9 child codes. In total, 40 ICD9-
CM codes are contained in ICD9 410.  
 
 	  
S5.2.2 Method to aggregate patient procedures 
 
The CCS procedure hierarchy was created to categorize ICD9 codes into 16 distinct types 
of medical operations and services. The hierarchy contains 4 levels where the top level 
(Level 1 procedure type), is the most general procedure category, level 2 and level 3 are 
subcategories, and level 5 contains only ICD9 codes. Each procedure category can have 
mappings to one or more ICD9 codes. For each patient, we aggregate procedures 
hierarchically by iteratively summing up the procedures beginning with the bottom of the 
hierarchy (ICD9 codes) and ending at the top of the hierarchy (most general procedure 
categories).  
 
The graph properties for disease terms also hold for procedure terms. For procedures, the 
root is 16 operations and the leaf terms are individual procedures.  
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S5.2.3 Graph properties of disease and procedure hierarchies 
 
Formally, the CCS disease hierarchy is a Directed Acyclic Graph (DAG) where the 
vertexes are labels denoting a disease category or ICD9 term. Each vertex in the 
hierarchy associates a more general category with a less general category (or ICD9 code 
mapping). Traversals of the hierarchy are either bottom-up or top down. In the methods 
reported here, aggregations are performed bottom-up from the ICD9 codes to the disease 
categories, recursively. The disease hierarchy is both a directed acyclic graph and an 
unbalanced tree: the number of subcategory vertices is not constant. The number of ICD9 
vertices is constant – there is only one edge between a diagnosis category and an ICD9 
code.  
 
To summarize the formal constraints of the disease hierarchy, it is a 1) directed acyclic 
graph, 2) unbalanced tree, 3) tree with depth five, 3) vertices are either disease categories 
or ICD9 codes, 4) disease category vertexes have depth less than or equal to four, 5) 
ICD9 code vertices all have tree depth five, 6) each ICD9 code has only one edge to a 
disease category.  
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S5.3 Summary 
 
Risk of heart attack varies across hospitals with respect to patient gender, age, and race. 
As expected, adult men have significantly higher risk of AMI compared to women. 
However, the risk for men can vary across different hospitals even when the gender 
proportions are similar. We use the relative risk equation as defined by Hidalgo et al[2].  
 
On average, men aged 18 and over have significantly higher risk of AMI than women in 
Massachusetts, risk (1.17 vs. 0.86) prevalence (3.5% vs. 2.6%). More women visited a 
Massachusetts hospital in this sample (55% vs. 45%), yet there are still far fewer cases of 
AMI in women compared to men (47%: 53%). Statewide average AMI prevalence was 
2.8% for patients aged 18 and older (Figure S5.2).  
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Figure S5.2 Statewide AMI risk by gender.  
 
Men have significantly higher risk of AMI than women in Massachusetts (1.17: 0.86), t-
test 95% confidence. The prevalence of AMI is also higher for men (3.5%: 2.6%). Higher 
number of women visited a Massachusetts hospital in this sample (55%: 45%), yet there 
are still fewer cases of AMI in women compared to men (47%: 53%).  
  
Statewide(AMI(Risk(By(Gender:((
All(pa7ents(aged(18+(
45%(Men( 55%(Women((
53%(Men( 47%(Women((
AMI$
Prevalence$
AMI$$
Rela.ve$Risk$
Men( 3.5%( 1.17$
Women( 2.6%( 0.86$
All#Pa&ents# 2.8%( 1$$
No$AMI$diagnosis$
Has$AMI$diagnosis$
#$Pa.ents$
$
%$Pa.ents$
$
Men( 1.23M( 45.4%$
Women( 1.47M( 54.5%$
All#pa&ents# 2.70M( 100%((
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Relative risk varied at different hospitals (Figure S5.2), because hospitals have differing 
AMI prevalence and gender distribution (Figure S5.3). AMI prevalence ranged from as 
low as 1% to 8%, even for hospitals with similar gender distributions.  
 
 
 
Figure S5.3 Histogram of relative risk by gender for all 73 hospitals meeting criteria.  
 
X-axis: relative risk by gender. Zero risk signifies no patients of that gender had an AMI 
diagnoses. RR=1 signifies no difference in AMI risk due to gender. RR=2 means all risk 
is for one gender. The relative risk of AMI due to gender is significant. Y-axis: Number 
of hospitals in the binned range.  
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Figure S5.4: Cumulative distribution of AMI patient visits by age.  
 
Green denotes patients who have no diagnosis of AMI at any visit. Red denotes patients 
with an AMI diagnosis. Blue denotes the difference in distributions. X-axis: the age of the 
patient at visit. A patient can visit one or more hospitals multiple times. Y-axis: 
cumulative sum of all patient visits. All patients in this sample have at least 3 visits 
(necessary for prediction). KS test confirms that AMI patients are significantly older than 
patients without AMI (p < .0005, distance=0.28±0.18). Equation 3 provides the test 
measurement for measuring the difference between AMI and unaffected patients in terms 
of patient age.  
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Figure S5.5. AMI patient age distributions: hospitals vs. state average. 
 
Each line represents one of the 73 hospitals. X-axis: patient age at visit.  
Y-Axis: difference in cumulative visits of AMI patients, average vs. one hospital. 
Y-max: Hospital cumulative visits are for younger patients than state average.  
Y-zero: Hospital cumulative visits are about the same as state average.  
Y-min: Hospital cumulative visits are for older patients.  
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Figure S5.6: Relative risk of AMI by race.  
 
Proportions of patient race varied considerably for each hospital compared to the 
statewide average (median). X-Axis: relative risk of AMI given patient reported race. 
Risks are calculated separately for each race as the proportion of AMI patients for each of 
race. Y-Axis:  Seven race codes were reported in the Massachusetts acute care setting. 
Race distributions varied considerably.  
 
 
!
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Figure S5.7 Procedure frequencies in Massachusetts by procedure type.  
 
The top 16 procedure categories are shown with percentages of all procedure codes 
recorded. In total, 73 hospitals were examined separately and each hospital contributed 
distributions for each category. X-Axis: proportion of procedure codes belonging to the 
category specified. Each boxplot contains results from 73 hospitals, where each hospital 
reports P (procedure category | hospital). Y-Axis: The 16 top procedure categories listed 
in the CCS procedures hierarchy. Red + signifies a hospital outlier. Blue ☐  signifies the 
25th and 75th percentiles averaged for all hospitals.  
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CHAPTER SIX SUPPLEMENT 
 
 
S6.1 Overview 	  
This chapter contains steps for selecting diagnosis and selecting procedures are the same, 
replacing only the word “diagnosis” with “procedure”. Only the steps for selecting 
associated diagnoses are written in full.  
 
Diagnoses and procedure frequencies were compared for patients with and without an 
AMI diagnoses. Each hospital was analyzed separately, with a total of 2.7 million adult 
patients and 73 hospitals. Diagnoses and procedures were aggregated (grouped) using the 
CCS hierarchies.   
 
The method selected a higher relative proportion of diagnosis and procedure categories 
compared to individual ICD9 codes. This finding suggests that the method is reducing 
medical coding variation.  
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S6.1 Steps for selecting associated diagnoses 
 
Step # Description 
1 For each hospital In network 
1.1 
 
Split the training population into two groups: the unaffected 
population and the AMI population. The unaffected population did 
not have an AMI diagnosis. The AMI population has an AMI 
recorded at a later visit date.  
 
1.2 
 
Aggregate patient diagnoses hierarchically as described chapter 2.6 
“Aggregate diagnoses”. The set of patient diagnoses now includes 
both diagnosis categories and ICD9 codes.  
 
 
1.3 Count the number of times each patient had each diagnosis. 
1.4 
 
If a patient had the same diagnosis more than 25 times, then limit 
the patient diagnosis to include only the first 25 occurrences. 
Patients very rarely have more than 25 diagnoses using the same 
ICD9 code. Patients sometimes have 25 or more diagnosis in the 
same diagnosis category. 
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1.5 
 
Count the number of patients having [0, 1, … 25] occurrences for 
each diagnosis in the set. The output of this step is the population 
frequency for each diagnosis (ICD9 codes and diagnosis 
categories). 
 
1.6 
 
Calculate the cumulative diagnosis distribution (CDF) from the 
population frequency. Cumulative sum the population frequency 
from 0 to 25 and divide the result by the last value. 
 
1.7 
 
Test the difference in cumulative diagnosis distributions (CDF). 
The null hypothesis states that the AMI population and the 
unaffected population have the same frequency of diagnoses for the 
diagnosis specified. The alternative hypothesis claims that AMI 
patients have the specified diagnosis much more often than the 
unaffected population (two sample KS test, 90% confidence). 
 
2 Combine association results from all hospitals. 
2.1 
 
For each level in the disease hierarchy, analyze each association. 
2.1.2 Count the number of hospitals reporting significance. 
2.1.3 Calculate mean p-value of hospitals responses 
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2.1.4 
 
Test if the number hospitals reporting significance is expected by 
the by the null hypothesis. The null hypothesis distribution is the 
binomial CDF, where the number of samplings is the number of 
hospitals (73) and the probability of success is 1 minus the mean p-
value of hospital results. The alternative hypothesis claims the 
actual number of hospitals with a significant finding is very 
different than expected given the p-value averages. 
 
2.1.5 Evaluate consensus criteria. We state an association has reached consensus if two criteria are met 
2.1.5.1 The number of hospitals reporting significance is higher than expected, given the average p-values reported (step 8.3) 
2.1.5.2 
The number of hospitals reporting significance is higher than the 
uncertainty in the test, in our case 7 hospitals could falsely report 
(73 hospitals * 10% test uncertainty). 
 
 
 
 
S6.2 Selected associated diagnoses 
 
The percentage of all diagnosis categories to ICD9 diagnosis codes is 5% to 95%, 
whereas the ratio of selections was 46% to 54%. The preferential selection of diagnoses 
categories is much higher compared to diagnosis ICD9 codes. Only one top-level 
diagnosis category was selected: “diseases of circulatory system”. This matched our 
expectation and provides some assurance that the method is working.   
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S6.3 Procedure selections 
 
 
The percentage all procedure categories to all ICD9 procedure codes was 10% vs. 90%, 
whereas the ratio of selections was 63% vs. 37%. Selection of procedures and selection of 
diagnoses were characteristically similar with regards to the percentage selected at each 
level in the hierarchy (excluding level 4 which only exists for diagnoses). Only one top-
level procedure category was selected: “operations on the cardiovascular system”. This 
matched our expectation.  
 
 
DIAGNOSES         All Categories ICD9 Codes 
Level L1 L2 L3 L4 L1 to L4 L5 
# Diagnoses 18 138 368 208 732 14904 
# Selected 1 6 21 8 36 78 
% Selected 5.60% 4.30% 5.70% 3.80% 4.92% 0.50% 
  
 
            
PROCEDURES         All Categories ICD9 Codes 
Level L1 L2 L3   L1 to L3 L5 
# Procedures 16 206 183   405 3924 
# Selected 1 5 2   8 5 
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% Selected 6.30% 2.40% 1.10%   1.98% 0.10% 
 
 
Table S6.1. AMI diagnoses and procedures selected by consensus.  
 
Selection results for AMI associated diagnoses (upper table) and associated procedures 
(lower table). All numbers and percentages are calculated separately for diagnoses and 
procedures. Highlighted: relative proportions of diagnoses and procedures selected for all 
categories vs. all ICD9 codes.  
 
 
 
S6.4 Aggregating weakly associated ICD9 codes can reveal strong 
relationships in diagnosis categories. 
 
 
ICD9 codes that individually have weak association can cumulatively have a strong 
association. More formally, the KS test statistic compares the cumulative distribution 
functions (CDF) for each diagnosis category. The KS test statistic is the CDF of the 
unaffected population minus the CDF of the affected population. The null hypothesis 
states that the unaffected population and the AMI population have about the same 
diagnosis frequency. This means that aggregating two or more ICD9 codes is analogous 
to aggregating their respective cumulative distribution functions. This is also true for 
subcategories. When two subcategories with CDFs greater for the AMI population are 
added together the difference is even greater for the AMI population vs. unaffected 
population.  
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S6.5 AMI associated diagnoses by disease system  
 
For each disease system, the highest scoring diagnosis category is shown in bold. If no 
diagnosis category was significant, the highest ICD9 code is chosen instead. Each row is 
one diagnosis in the hierarchy. Each diagnosis can either be a diagnosis category or an 
individual ICD9 code. The level and number of ICD9 codes (#codes) are shown for the 
diagnosis. Individual ICD9 codes have level 5 (L5) and the code is printed in the 
description. Relative risk mean and stdev scores are from 73 hospitals. Consensus 
diagnoses associations were calculated for the number of hospitals (#H) reporting 
significantly greater frequencies of the diagnosis for AMI patients.  
 
Risk	  legend Risk	   Risk score for the diagnosis reaching consensus  Mean	   Mean risk score of 73 hospitals Std	   Standard deviation of 73 hospital risk responses 
	  
Method	  legend	  	  Voting	   Hospitals agree that the diagnosis specified significantly increases 
AMI risk.  
 #hosps	   Number of hospitals independently reporting significant 
differences between AMI vs. unaffected patients  
 #level	   Level in the diagnosis hierarchy:  
L1= disease system. 
L2= general diagnosis category.  
L3= more specific diagnosis category. 
L4= most specific diagnosis category. 
L5= single diagnosis (ICD9 code).  
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Empty value signifies the default (ICD9 code).  
 #icd9	   Number of ICD9 codes in diagnosis category.  
 	  
Diagnosis	  legend	   Diagnosis	   Category	  of	  diagnosis	  or	  specific	  ICD9	  diagnosis.	  	  
Each row is one diagnosis in the hierarchy.  
Each diagnosis can either be a diagnosis category or an individual 
ICD9 code 	  
Bold	   Highest scoring diagnosis category. If no diagnosis category 
was significant, the highest ICD9 code is chosen. 	  
 
 
 
S6.6 Circulatory system: diseases of arteries and capillaries  
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #hosp	   #level	   #icd9	   Diseases	  of	  the	  circulatory	  system	  
	   	   	   	   	   	  
1.58	   ±	  0.19	   71	   L1	   618	   Diseases	  of	  the	  circulatory	  system	  
2.37	   ±	  0.4	   35	   L2	   124	   Diseases	  of	  arteries;	  arterioles;	  and	  
capillaries	  	  
3.2	   ±	  0.65	   23	   L3	   19	   Peripheral	  and	  visceral	  atherosclerosis	  
2.8	   ±	  0.6	   16	   L4	   2	   Peripheral	  vascular	  disease	  
unspecified	  	  
4.09	   ±	  0.92	   16	   	   1	   Peripheral	  vascular	  disease	  
unspecified	  (icd9:443.9)	  
 
 
Risk of heart attack for patients with peripheral and visceral atherosclerosis. The risk of 
heart attack due to PVD has also been reported, with recommended treatment of 
inflammatory response[3]. Peripheral vascular disease is commonly diagnosed in patients 
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with heart disease.  
 
S6.7 Circulatory system: hypertension  
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #hosp	   #level	   #icd9	   Diseases	  of	  the	  circulatory	  system	  
	   	   	   	   	   	  
1.58	   ±0.19	   71	   L1	   618	   Diseases	  of	  the	  circulatory	  system	  
1.72	   ±0.28	   12	   	   1	   Essential	  hypertension	  	  (ICD9:	  401.9)	  
2.94	   ±0.63	   32	   L3	   41	   	  Hypertension	  with	  complications	  and	  secondary	  HT	  
	  
2.45	   ±0.54	   31	   L4	   31	   Hypertensive	  heart	  and/or	  renal	  disease	  	  
4.15	   ±1.23	   34	   	  
	  1	   Hypertensive	  chronic	  kidney	  disease,	  unspecified,	  with	  chronic	  kidney	  disease	  
stage	  V	  or	  end	  stage	  renal	  disease	  (ICD9:	  
403.91)	  
4.15	   ±1.23	   34	   	  
	  1	   Hypertensive	  chronic	  kidney	  disease,	  unspecified,	  with	  chronic	  kidney	  disease	  
stage	  V	  or	  end	  stage	  renal	  disease	  (ICD9:	  
403.91)	  
 
 
Risk of heart attack for patients with hypertension. Hypertension is known to increase the 
risk of heart attack and atherosclerosis[4]. Patients with hypertension are about twice or 
three times as likely to have a heart attack. Patients with hypertensive chronic kidney 
disease have about a 3X to 5X risk of heart attack. It is worth noting that “other 
hypertensive complications” had RR both higher and lower than 1 within one standard 
deviation, so the method did not select the entire a category with all hypertension 
diagnosis. 
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S6.8 Diseases of endocrine; nutritional; metabolic diseases; immunity 
disorders 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #hosp	   #level	   #icd9	   Endocrine;nutritional;metabolic;immune	  
1.72	   0.27	   0	   L1	   474	   Endoes;	  immunity	  	  
2.23	   ±0.36	   26	   L2	   13	   Diabetes	  mellitus	  without	  complication	  	  	  
2.25	   ±0.42	   21	   	   1	   Diabetes	  mellitus	  without	  complication	  	  
(icd9:250.00)	  
2.91	   ±0.66	   16	   	   1	   Diabetes	  mellitus	  without	  complication	  	  
(icd9:250.01)	  
3.00	   ±0.47	   66	   L2	   65	   Diabetes	  mellitus	  with	  complications	  
2.82	   ±1.77	   7	   	   1	   Diabetes	  with	  ketoacidosis	  or	  
uncontrolled	  (icd9:250.11)	  
4.35	   ±1.05	   30	   L3	   7	   Diabetes	  with	  renal	  manifestations	  	  
4.82	   ±1.27	   12	   	   1	   Diabetes	  with	  renal	  manifestations	  
(icd9:250.40)	  
3.18	   ±0.63	   19	   L3	   7	   Diabetes	  with	  neurological	  
manifestations	  	  
3.46	   ±0.76	   8	   	   1	   Diabetes	  with	  neurological	  
manifestations	  (icd9:250.60)	  
6.08	   ±11.60	   10	   	   1	   Diabetes	  with	  neurological	  
manifestations	  (icd9:250.61)	  
2.17	   ±0.32	   16	   L3	   21	   Diabetes	  with	  other	  manifestations	  	  
1.96	   ±1.45	   9	   	   	   Other	  endocrine	  disorders	  	  (icd9:255.4)	  
1.45	   ±0.20	   10	   	   1	   Hypovolemia	  (icd9:276.5)	  
1.18	   ±0.21	   15	   L3	   27	   Other	  thyroid	  disorders	  	  
1.44	   ±0.31	   15	   	   1	   Other	  thyroid	  disorders	  (icd9:244.9)	  
 
 
Risk of heart attack for patients with diabetes. The highest risk of AMI for any 
diabetic diagnosis is “diabetes with renal manifestations”. Patients with severe diabetes 
can also experience severe kidney failure. The American Heart Association issued a 
warning that kidney disease is a very strong risk factor for heart disease[5].  
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Many other diabetes diagnoses were also selected by the consensus method, including 
diabetes without complications. Importantly, the relative risk of heart attack increases for 
diabetes with complications, especially “diabetes with neurological manifestations”. The 
increased risk of AMI due to diabetes with neurological manifestation has been 
reported[6].  
 
In general, diabetes is known to increase AMI risk. A clinician expert may use the above 
list to create a point system for each category of diabetes complications: renal, 
neurological, any complication, or no complication. 
 
S6.9 Diseases of the blood and blood-forming organs 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #hosp	   #level	   #icd9	   Diseases	  of	  the	  blood	  &blood-­‐forming	  organs	  
2	   ±0.37	   0	   L1	   140	   Diseases	  of	  the	  blood	  &blood-­‐forming	  organs	  
1.59	   ±0.24	   16	   L3	   50	   Deficiency	  and	  other	  anemia	  
1.97	   ±0.50	   7	   	   1	   Chronic	  blood	  loss	  anemia	  (icd9:2800)	  
1.89	   ±0.36	   8	   	   1	   Anemia;	  unspecified	  (icd9:2859)	  
 
 
Risk of heart attack for patients with a blood disease. Anemia is a decrease in red blood 
cells that deliver oxygen. It is therefore unsurprising that anemia was the highest scoring 
category of blood diseases.  This finding is well documented for patients with AMI[7].  
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S6.10 Diseases of the genitourinary system 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #hosp	   #level	   #icd9	   Diseases	  of	  the	  genitourinary	  system	  
1.25	   ±0.07	   0	   L1	   549	   Diseases	  of	  the	  genitourinary	  system	  
1.32	   ±0.09	   24	   L2	   239	   Diseases	  of	  the	  urinary	  system	  
2.52	   ±0.55	   42	   L3	   18	   Chronic	  renal	  failure	  	  
3.97	   ±1.14	   18	  
	  
1	   Chronic	  kidney	  disease	  (icd9:	  585)	  
2.57	   ±1.36	   14	  
	  
1	   End	  stage	  renal	  disease	  (icd9:	  585.6)	  
2.34	   ±2.45	   23	   	   1	   Kidney	  replaced	  by	  transplant	  (icd9:	  V420)	  
4.13	   ±1.78	   14	   	   1	   Post	  surgical	  renal	  dialysis	  (icd9:	  V451)	  
1.23	   ±0.14	   8	   	   1	   Urinary	  tract	  infection;	  site	  not	  specified	  (icd9:5990)	  
 
 
Risk of heart attack for patients with chronic renal failure. Kidney problems are known to 
increase the risk of heart attack. The American Heart Association has issued statements 
and guidance for case management[5].  
 
There are two types kidney failure: acute and chronic. Acute kidney failure can often be 
treated, whereas chronic kidney failure is a lifelong illness. The relative risk of AMI for 
these patients is roughly 2X to 3X higher than patients without chronic kidney failure. 
Note that of all kidney diagnosis, post surgical renal dialysis posed the highest risk of 
AMI (~2X to 6X).  
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S6.11 Diseases of the respiratory system 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #icd9	   Diseases	  of	  the	  respiratory	  system	  
1.05	   ±0.05	   0	   	  L1	   356	   Diseases	  of	  the	  respiratory	  system	  
1.72	   ±0.27	   28	   	  L2	   20	   COPD	  and	  bronchiectasis	  	  
2.06	   ±0.32	   28	   	  L3	   2	   Chronic	  airway	  obstruction;	  NOS	  
2.39	   ±0.41	   28	  
	  
1	  
Chronic	  airway	  obstruction;	  NOS	  
(icd9:496)	  
1.95	   ±0.34	   31	   	  L3	   5	   Obstructive	  chronic	  bronchitis	  
2.31	   ±0.45	   29	   	   	  1	   Obstructive	  chronic	  bronchitis	  (icd9:49121)	  
 
 
Risk of heart attack for patients with COPD or respiratory diagnoses. Chronic airways 
obstruction the flow of blood and oxygen and can increase the risk of a heart attack[8]. 
Risk and severity of COPD and AMI are both strongly increased by smoking.  
 
	  
S6.12 Infectious and parasitic diseases 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #icd9	   Infectious	  and	  parasitic	  diseases	  
0.92	   ±0.13	   0	   L1	   1241	   Infectious	  and	  parasitic	  diseases	  
0.58	   ±0.63	   8	  
	  
1	  	   HIV	  infection	  (icd9:042)	  
 
 
Risk of heart attack for patients with HIV. HIV drugs can increase the risk of heart 
attack[9]. Until recently the risk of AMI due to HIV (not the drugs) was unknown. A 
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recent study shows that HIV patients living longer with antiretroviral medications are at 
increased risk of AMI:  
 
“HIV infection is independently associated with AMI after adjustment for Framingham 
risk, comorbidities and substance use. Unsuppressed HIV viremia, low CD4 cell count, 
Framingham risk factors, hepatitis C virus, renal disease and anemia are also associated 
with AMI [10]”  
 
 
S6.13 Diseases of the nervous system and sense organs 
 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #icd9	   Diseases	  of	  the	  nervous	  sys	  and	  sense	  organs	  
0.87	   ±0.05	   0	   L1	   1614	  
	  1.7	   ±0.58	   8	  
	  
1	   Parkinsons	  disease	  (icd9:3320)	  
0.68	   ±0.47	   10	  
	  
1	   Multiple	  sclerosis	  (icd9:340)	  
3.55	   ±1.88	   7	  
	  
1	  
Peripheral autonomic neuropathy 
(icd9:3371)	  
0.99	   ±0.22	   13	  
	  
1	   Convulsions	  (icd9:78039)	  
5.19	   ±4.50	   11	   	   1	  
Background diabetic retinopathy 
(icd9:36201)	  
1.49	   ±0.22	   16	   L3	   83	   Disorders	  of	  the	  peripheral	  nervous	  system	  
3.74	   ±0.88	   10	   	   1	   Disorders	  of	  the	  peripheral	  nervous	  system	  (icd9:3572)	  
 
 
Risk of heart attack for patients with diabetic retinopathy. Studies show that background 
retinopathy predicts Coronary Heart Disease[11]. It is worth noting that this finding had 
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high variation when measured across all hospitals, whereas 11 hospitals reported this 
association with >90% confidence.  
 
 
 
S6.14 Diseases of musculoskeletal system and connective tissue 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #icd9	   Musculoskeletal	  system	  and	  connective	  tissue	  
0.88	   ±0.07	   0	   L1	   887	   Musculoskeletal	  system	  and	  connective	  tissue	  
1.52	   ±0.39	   17	   L3	   13	   Rheumatoid	  arthritis	  and	  related	  dx	  
1.82	   ±0.50	   16	  
	  
1	  
Rheumatoid	  arthritis	  and	  related	  dx	  (ICD9:	  
7140)	  
1.18	   ±0.79	   16	  
	  
1	  
Systemic	  lupus	  erythematosus,	  	  
connective	  tissue	  dx	  (icd9:7100)	  
4.15	   ±2.04	   10	  
	  
1	   Below knee amputation (icd9:V4975)	  
 
 
Risk of heart attack for patients with rheumatoid arthritis and related muscle/tissue 
diseases. A previous study reported that the rheumatoid arthritis nearly doubles the risk of 
AMI [12]. This is within one standard deviation of our finding. Results reported here 
could have lower risk due to age differences between our populations and the previously 
reported study population.  
 
 
 
S6.15 Neoplasms 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #codes	   Neoplasms	  
	  	  
50 
1.38	   ±0.24	   0	   L1	   1131	   Neoplasms	  
2.37	   ±1.50	   8	  
	  
1	  	   Cancer	  of	  bladder	  (icd9:V1051)	  
1.94	   ±1.74	   8	  
	  
1	  	   Leukemias	  (icd9:204.10)	  
1.95	   ±1.49	   12	  
	  
1	  	   Multiple	  myeloma	  (icd9:203.00)	  
 
Risk of heart attack for patients with cancer. Of all cancers evaluated, bladder cancer 
raised the risk of AMI the most. Patients with bladder cancers were roughly 2X to 4X 
more likely to have an AMI compared to patients without bladder cancer. This finding 
has been sparsely reported[13], and attributed to chronic hyperlipidemia. The risk of AMI 
been reported in patients with “acute myeloid luekimia”[14].  
 
In general, cancer and heart attack share more risk factors than underlying disease 
biology. This makes it challenging to control for confounding factors such as smoking 
status and other life style choices [15].  
 
Importantly, the consensus method is not selecting many cancers, even though many 
cancers are highly prevalent and AMI has higher than average diagnoses in most disease 
categories. This provides additional assurance that the consensus method is working.  
 
 
 
S6.16 Mental illness and substance abuse 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #codes	   Mental	  illness	  and	  substance	  abuse	  
	  	  
51 
1.25	   ±0.48	   7	  
	  
1	   Tobacco use disorder (icd9:3051)	  
0.96	   ±0.58	   11	  
	  
	  1	   Alcoholic	  cirrhosis	  of	  liver	  (icd9:5712)	  
 
Risk of heart attack for smokers and alcoholics. Smoking increases the risk of heart 
attack[16] and is a key criteria of the Framingham Risk Score[17].  
 
 
 
S6.17 Diseases of the digestive system 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #codes	   Diseases	  of	  the	  digestive	  system	  
1.05	   ±0.06	   0	   	  L1	   837	   Diseases	  of	  the	  digestive	  system	  
1.32	   ±0.26	   8	  
	  
	  1	   Other	  esophageal	  disorders	  (icd9:53081)	  
2.06	   ±1.00	   10	  
	  
1	  
Other	  disorders	  of	  stomach	  and	  duodenum	  
(icd9:5363)	  
0.83	   ±0.61	   10	  
	  
	  1	  
Regional	  enteritis	  and	  ulcerative	  colitis	  
(icd9:5559)	  
1.00	   ±0.22	   15	   	  L3	   28	   Other	  liver	  diseases	  [151.]	  
1.13	   ±0.65	   9	   	   	  1	   Chronic	  pancreatitis	  (icd9:5771)	  
1.31	   ±1.22	   7	   L5	   	  1	   Other	  gastrointestinal	  disorders	  (icd9:V442)	  
 
 
Risk of heart attack for patients with liver diseases. Liver enzymes aspartate transaminase 
and alanine transaminase are associated with ST-elevations in patients with AMI[18].  
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S6.18 Injury and poisoning 
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #icd9	   	  
0.65	   ±0.06	   0	   	  L1	   2786	   Injury	  and	  poisoning	  
2.12	   ±0.42	   14	   	  L3	   90	   Complication	  of	  device;	  implant	  or	  graft	  
 
Risk of heart attack for patients having implant complications. Complications with 
pacemakers and implantable cardioverter-defibrillators can cause problems for patients at 
risk of heart attack[19].  
 
 
 
S6.19 Unclassified diagnoses 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #H	   Level	   #codes	   	  
0.6	   ±0.05	   0	   	  L1	   1589	   Residual	  codes;	  unclassified;	  all	  E	  codes	  
1.41	   ±0.56	   12	   L5	  
	  
Unspecified	  sleep	  apnea	  (icd9:78057)	  
 
 
Risk of heart attack for patients with sleep apnea.  
The prevalence of obstructive sleep apnea is high for patients with AMI[20].  
 
 
 
S6.20 Selections by operation type  
 
 
Risk	   Consensus	   Diagnosis	  
mean	   std	   #hosp	   #level	   #icd9	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1.58	   ±0.19	   64	   L1	   357	  
Operations	  on	  the	  cardiovascular	  
system	  
0.82	   ±0.12	   24	   L2	   12	   Diagnostic	  cardiac	  catheterization;	  	  coronary	  arteriography	  
1.37	   ±0.44	   46	   L2	   2	   Hemodialysis	  
0.76	   ±2.86	   46	   L5	  
	  
Hemodialysis(icd9:3995)	  
0.34	   ±0.08	   9	   L2	   84	   Other	  OR	  procedures	  on	  vessels	  	  other	  than	  head	  and	  neck	  
0	   ±0.00	   7	   L5	   	   Other	  non-­‐OR	  therapeutic	  	  cardiovascular	  procedures.	  (icd9:3895)	  
 
 
Risk of heart attack for patients who had a cardiovascular operation. Consensus method 
reported that only cardiovascular operations increase the risk of an AMI. Note that these 
procedures were selected as significant before the first AMI episode. Hemodialysis is 
used to treat renal failure, a known comorbidity of heart attack. Furthermore, 
hemodialysis can lead to endocarditis (inflammation endocardium) which is known to 
increase heart attack risk[21].  
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CHAPTER SEVEN SUPPLEMENT 
 
S7.1 Baseline model for each local patient population 
 
 
Step # Description 
1	  
	  
Split	  each	  hospital	  into	  2/3	  training	  and	  1/3	  testing	  populations.	  
This	  split	  is	  done	  randomly	  for	  each	  hospital.	  Patients	  are	  either	  
members	  of	  the	  training	  set	  or	  the	  test	  set.	  We	  preserve	  the	  split	  
of	  the	  training	  and	  test	  populations	  to	  allow	  for	  model	  
comparisons.	  	  
	  
2	  
	  
Construct	  a	  patient	  history	  for	  each	  patient.	  The	  patient	  history	  is	  
a	  sparse	  feature	  matrix	  where	  the	  rows	  are	  patients	  and	  the	  
columns	  are	  features.	  Features	  include	  patient	  diagnosis,	  
procedures,	  demographics,	  and	  type	  of	  department	  visit.	  Elements	  
in	  the	  feature	  matrix	  are	  counts	  of	  the	  feature.	  In	  the	  baseline	  
model	  we	  do	  not	  aggregate	  diagnoses	  or	  procedures.	  For	  HIPAA	  
privacy	  protection,	  we	  remove	  any	  feature	  having	  fewer	  than	  100	  
patients.	  	  
	  
3	  
	  
Train	  a	  prediction	  model	  using	  only	  the	  training	  population.	  The	  
classifier	  type	  is	  Naïve	  Bayes	  and	  the	  distribution	  type	  is	  
multinomial	  (Matlab	  R2013A	  NBC	  function).	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4	  
	  
Test	  the	  prediction	  model	  on	  the	  test	  population	  at	  90%	  
specificity.	  	  
	  
 
Measurements 
Gather test results from all hospitals. Test results include the prediction accuracy 
(sensitivity at 90% specificity and AUC), and population characteristics (number 
of patients, number of AMI patients, and AMI prevalence). Compare the 
population characteristics to the accuracy of the predictions.  	  
 
S7.2 Baseline model: train at MGH and test on each hospital 
 
 
 
Step # 
 
Description 
1	  
 
Select the baseline model that was trained using only the 
MGH patient population (1 training set).  
	  
2	  
 
For each hospital in network (73 test sets):  
	  
3	  
	  
Test the baseline MGH model on the hospital patient 
population.   
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Measurements  
Gather test results from all hospitals. Compare the prediction accuracy of the 
MGH model to the prediction accuracy at each hospital. Measurements include 
sensitivity at 90% specificity and AUROC.  
 
 
S7.3 Baseline model: train at each hospital, test on MGH  
 
 
 
Step # 
 
Description 
1	  
 
For each hospital in network (73 training sets):  
	  
2	  
 
Select the baseline model that was trained on the local 
patient population.  
	  
3	  
	  
Test the local baseline on the MGH patient population (1 test 
set). 	  
	  
 
 
Measurements: 
Gather test results from all hospitals. Compare the prediction accuracy of each 
hospital model to the prediction accuracy of the MGH model. Measurements 
include sensitivity at 90% specificity and AUROC.  	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S7.4 Selecting associations for AMI risk prediction 
 
Comorbidity model for each local patient population 
The comorbidity model uses the same sets of patients and the same set of patient 
demographic features as the baseline model. The comorbidity model uses the features 
selected by the comorbidity methods reported in chapter 6.  
 
Note that the steps for each hospital are the same for the comorbidity prediction model as 
the baseline prediction model. The only difference is in the features selected for training. 
We kept all other conditions the same to allow for comparison.  
 
 
Step # 
 
Description 
1	  
	  
For	  each	  hospital	  in	  network	  (73	  patient	  populations):	  	  
	  
2	  
	  
Select the same 2/3 training and 1/3 test split as the baseline 
local patient population described above.	  
	  
3	  
	  
Construct a patient history for each patient. Features include 
the comorbidities and risk factors selected using the 
comorbidity consensus method. The comorbidity model uses 
the same patient diagnoses and visit types as the baseline 
model. For HIPAA privacy protection, we remove any feature 
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having fewer than 100 patients.	  
	  
4	  
Train a prediction model on the local patient population. 
(1 train set for each patient population). 	  
	  
5	  
Test the prediction model on the local patient population.  
(1 test set for each patient population). 
 
 
Measurements: 
Compare the prediction accuracy (sensitivity at 90% specificity, AUC) between 
the baseline prediction model and the comorbidity prediction model. 
 
 
Comorbidity model: Train at MGH, test on each hospital 
 
 
 
Step 
 
Description 
1 
 
For each hospital in network:  
 
2 
 
 
Select the comorbidity model that was trained using only the MGH 
local patient population (1 training set).  
 
3  
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Test the comorbidity model from MGH on all other hospitals (73 
test sets). 
 
4 
 
Record the prediction accuracy.  
 
 
Measurements:  
Gather test results from all hospitals. Compare the prediction accuracy of the 
MGH model to the prediction accuracy each hospital. Measurements include 
sensitivity at 90% specificity and AUROC.  
 
 
S7.5 Consensus models for robust AMI prediction in hospital networks 
 
The network method combines the results of many individual predictions into one 
prediction. The input of the network method is the prediction output of the comorbidity 
prediction. The network method combines the predictions from all hospitals using logistic 
regression (Matlab R2013A) Note: the network method only applies to the network 
scenario. The network method is customizable to each hospital.  
 
 
 
	  
Step	  	  #	  
	  
Description	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1	  
	  
Select	  a	  target	  hospital	  population	  (example:	  MGH)	  	  
	  
2	  
	  
	  
Gather the comorbidity prediction models (NBC classifiers) from 
all hospitals in network (73 training sets).  
	  
3	  
	  
Train a logistic regression model on the local 2/3 training 
population. (Equation 3.2)  
 
4	  
 
Test the logistic regression accuracy on the local 1/3 testing 
population.  
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Comorbidity model: Train on each hospital, test at MGH  
 
	  
Step	  #	  
	  
Description	  
1	  
	  
For	  each	  hospital	  in	  network	  (73 training sets):	  	  
	  
2	  
	  
	  
Select the comorbidity model that was trained using the local 
patient population.  
	  
3	  
	  
Test each model on the MGH patient population (1 test set).  
 
4	  
 
Record the prediction accuracy.  
	  
 
Measurements:  
Gather test results from all hospitals. Compare the prediction accuracy of each hospital 
model to the prediction accuracy of the MGH model. Measurements include sensitivity at 
90% specificity and AUROC.  	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S7.6 Prediction results summary 
 
 
Compared to the baseline performance, the comorbidity based risk model had higher 
average sensitivity for all scenarios tested and higher sensitivity for most hospitals. The 
comorbidity method also had higher performance for models trained in one hospital 
setting and tested in a different setting. This suggests that the comorbidity method is 
reducing medical coding variation and increasing the reproducibility of heart attack 
predictions. Combining comorbidity risk models from multiple hospitals yielded the 
highest performance, even for the largest hospital in the state (MGH).  
 
Hospital size was not strongly associated with AMI prediction accuracy in the local 
hospital setting. MGH is the largest hospital, has the largest number of AMI cases, and 
average disease prevalence. However, MGH had average prediction accuracy training 
and testing on the MGH population. In 73 different hospital settings, we found no strong 
association between hospital size and local prediction accuracy. Similarly, the number of 
heart attack cases was not a strong indicator of local prediction accuracy. Only when the 
proportions of hospital size to case size are combined do we see strong affects: disease 
prevalence is strongly associated with prediction accuracy. Hospitals with higher AMI 
prevalence generally had worse prediction performance. One explanation for this finding 
is that an increase in AMI prevalence means a general increase for comorbidities in the 
population, making it more difficult to discriminate “healthy” unaffected patient from “at 
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risk” AMI patients. 
 
Training on the largest hospital (MGH) and testing at other hospitals was generally better 
compared to training on smaller hospitals. In fact, the MGH model was sometimes better 
at other hospitals. Compared to other hospitals, MGH was a good training model for 
other hospitals but it was certainly not the best model at all hospitals: performance varied 
from 43% to 83%. Contrary to expectation, the MGH model performed better for small 
hospitals than for large hospitals and the trend was slightly downward. Interestingly, the 
MGH model often performed better in hospital populations that were dissimilar from the 
local MGH population in terms of population size, AMI case size, and AMI prevalence.  
 
The accuracy of the prediction models was not symmetric: if MGH performed well at 
another hospital there is no guarantee that the other hospital will have good test 
performance at MGH. Matching patient populations is not enough, it is also necessary 
reduce hospital coding biases.  
 
The comorbidity risk model reduced variation in both medical coding and AMI risk 
factors. Medical coding variation was reduced in two phases: aggregation and 
comorbidity consensus. In AIM3 we discuss these topics in detail, the important finding 
for AMI prediction is that reducing variation and increasing risk model consensus 
positively affects prediction accuracy. The comorbidity model was higher performing in 
the local patient population setting, the MGH model setting, and the network prediction 
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setting. We how figures for his finding and provide further supporting evidence.  
 
When multiple hospitals were combined into a single model (meta-classifier), the result 
was much better even for the most challenging case (MGH). Most hospitals individually 
had low AMI prediction accuracy for MGH patients. However, taken together as a 
consensus measure the network was significantly higher (76% network model, 66% local 
MGH baseline, 64% MGH comorbidity model).  
 
Lastly, we found that hospitals with similar patient geographies often have similar heart 
attack prediction outcomes across all other hospitals in the state. For example, the MGH 
prediction accuracy was most similar BWH, Faulkner, BIDMC, and hospitals in the 
Longwood Medical Area. In this cluster were other general hospitals, and their 
population sizes varied. It would be interesting to follow up with this finding in future 
work to weight network prediction using patient geographies and hospital types.  
 
In summary, consensus methods for selecting heart attack risk factors and predicting 
heart attacks at other hospitals reduce variation and increase the accuracy of heart attack 
predictions. Hospital size did not equate to better performance, however, prevalence 
played an important role in nearly every scenario we evaluated. Our approach is search 
for evidence in agreement from many hospitals rather than rely on a single large 
population of any size. We show that this methodology yields better prediction 
performance for local heart attack predictions and predictions between MGH and other 
hospitals. Nearly all hospitals were found to have improved heart attack prediction 
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accuracy for both the local patient population and patient population at another hospital.  
 
The remainder of this chapter quantifies and visualizes the evidence for the findings 
reported for each model (baseline, comorbidity, and network). For each finding, we 
provide a supporting figure and the rationale for the finding. Findings are reported in the 
order in which they were discovered and verified in the comorbidity and network models.  
 
 
S7.7 Baseline model AMI prediction results  
 
AMI prediction models were trained and tested on each hospital population. In total, 73 
hospitals were analyzed separately and later tested on the MGH population. For all 
hospitals, specificity was controlled at 90%. Baseline AUC was 89±2% and sensitivity 
was 64±8%. The highest sensitivity was Boston Medical Center (82%), the second 
highest sensitivity was Cambridge Health Alliance (81%), and the sensitivity for the 
largest hospital (MGH) was 65%. The lowest sensitivity was for a hospital in Lawrence 
(48%).  We compared the accuracy of the predictions to the characteristics of the 
populations.  
 
 
Finding: Heart attack prevalence in each health care setting is a stronger 
indicator of prediction accuracy than AMI case size or population size.  
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Population Size 
MGH is the largest hospital in Massachusetts and sees more AMI cases than any 
other hospital. Nonetheless, the baseline prediction model for MGH was about 
the same as the average hospital. Boston Medical Center (BMC) had the highest 
(82%) sensitivity and is a large hospital. A hospital in Cambridge had nearly the 
same sensitivity (81%) as BMC using a much smaller population. A hospital in 
Lawrence had the lowest sensitivity and a population size similar to the 
Cambridge hospital. These four cases show that a hospital can have high or low 
prediction sensitivity using a small or large patient population.  
 
AMI case size  
We next analyzed the influence of AMI case size on prediction sensitivity. Larger 
case sizes were weakly associated with prediction sensitivity, and the trend was 
downward. This is because as case sizes increase, also AMI prevalence also 
tends to increase.  
 
AMI Prevalence 
Hospitals with higher AMI prevalence were shown to have generally lower 
prediction sensitivity compared to hospitals with lower AMI prevalence. Of note, 
precision increased as AMI prevalence also increased which was expected.  
 
	  
#	  Patients	   #	  Cases	   Prevalence	   Sensitivity	   AUC	  
Boston	  (MGH)	   Highest	   Highest	   Average	   65%	  	   89%	  
Boston	  (BMC)	   High	   Average	   Low	   82%	   90%	  
Cambridge	   Low	   Low	   Low	   81%	   91%	  
Lawrence	   Low	   Average	   High	   48%	   86%	  
 
Table S7.1: Summary of baseline accuracy for hospitals with different population 
sizes, case sizes, and prevalence.  	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Finding: Baseline heart attack predictions from MGH were very similar to 
predictions using the local patient population. Predictions for each hospital varied 
from 43% to 83% sensitivity at 90% specificity. 
 
The MGH baseline was trained using 2/3 of all MGH patients and tested on 1/3 of the 
patients at each hospital in Massachusetts. The results of the MGH test were compared to 
the results of the local prediction scenario (train 2/3 each hospital, test 1/3 each hospital). 
In general, the performance of the MGH model was very characteristically similar. 
Sensitivity was -1 ±08% for MGH compared to the local model. Sensitivity was 
sometimes better and sometimes worse than the local model. The MGH model was better 
for 35 hospitals and worse for 37 hospitals.  
 
Heart attack predictions that were trained on the local MGH population and tested in 
other clinical settings had descent prediction sensitivity for heart attack diagnoses (66 
±8%). The performance of the MGH model was nearly the same compared to the 
performance of the local model for each hospital. However, results still varied from 83% 
(Cambridge Health Alliance) to 43% (Lahey Clinic). Of note, the MGH model had a 
slight tendency to be better for hospitals that saw fewer AMI cases.  
 
Predictions trained on the MGH population were not strongly associated with AMI 
prevalence in the testing population. This is important to note because MGH has average 
AMI prevalence for hospitals in Massachusetts (~3% prevalence of AMI for all adult 
patients aged 18 and over). 
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